Onderneming Corbus Pharmaceuticals Holdings, Inc.
Aandelen
CRBP
US21833P3010
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
38,77 USD | +1,49% | +13,20% | +541,89% |
Vakgebied
Aantal werknemers: 19
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Yuval Cohen
CEO | Chief Executive Officer | 49 | 01-07-13 |
Sean Moran
DFI | Director of Finance/CFO | 66 | 11-04-14 |
Chief Tech/Sci/R&D Officer | 50 | 28/02 | |
Human Resources Officer | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Alan Holmer
CHM | Chairman | 74 | 01-01-14 |
Avery Catlin
BRD | Director/Board Member | 75 | 01-08-14 |
Yuval Cohen
CEO | Chief Executive Officer | 49 | 01-07-13 |
John Jenkins
BRD | Director/Board Member | 66 | 05-06-18 |
Jacques Suzanne
BRD | Director/Board Member | 53 | 08-04-19 |
Yong Ben
BRD | Director/Board Member | 50 | 01-03-23 |
Peter Salzmann
BRD | Director/Board Member | 56 | 06-03-20 |
Anne Altmeyer
BRD | Director/Board Member | 59 | 20-09-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 10 507 237 | 10 434 476 ( 99,31 %) | 0 | 99,31 % |
Bedrijfsgegevens
Corbus Pharmaceuticals Holdings, Inc.
500 River Ridge Drive Second floor
02062, Norwood
+617 963 0100
http://www.corbuspharma.comSector
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+541,89% | 407 mln. | |
-1,43% | 104 mld. | |
+8,96% | 105 mld. | |
+4,40% | 22,94 mld. | |
-12,15% | 22,34 mld. | |
-4,36% | 19,25 mld. | |
-39,98% | 17,08 mld. | |
-10,04% | 16,96 mld. | |
+6,79% | 14,16 mld. | |
+38,61% | 12,63 mld. |
- Beurs
- Aandelen
- Koers CRBP
- Onderneming Corbus Pharmaceuticals Holdings, Inc.